Sign up to save your podcasts
Or
Share Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
Paper discussed in today's episode:
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
View all episodes
By American Thoracic Society
4
3636 ratings
Paper discussed in today's episode:
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
More shows like Out of the Blue: An AJRCCM Podcast
View all
JAMA Editors' Summary
138 Listeners
EMCrit FOAM Feed
1,866 Listeners
NEJM This Week
323 Listeners
CHEST Journal Podcasts
63 Listeners
ATS Breathe Easy
36 Listeners
JAMA Clinical Reviews
500 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,138 Listeners
Annals On Call Podcast
192 Listeners
The Internet Book of Critical Care Podcast
701 Listeners
Run the List
249 Listeners
Critical Care Scenarios
253 Listeners
The Curious Clinicians
374 Listeners
Critical Care Time
235 Listeners